| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/14/1989 | CA1249968A1 Ointment base |
| 02/09/1989 | WO1989001033A1 Conjugates of superoxide dismutase |
| 02/09/1989 | WO1989000855A1 Polyanhydrides with improved hydrolytic degradation properties |
| 02/09/1989 | WO1989000853A1 Agent containing salicylic acid for treating lepidosis |
| 02/09/1989 | WO1989000839A1 Therapeutic agent delivery system |
| 02/09/1989 | WO1988009181A3 Monoclonal antibodies neutralizing hiv-1 |
| 02/09/1989 | DE3725056A1 Stable liquid o/w emulsion |
| 02/08/1989 | EP0302836A1 Pharmaceutical compositions for topical use containing miocamycin |
| 02/08/1989 | EP0302772A1 Calcitonin composition for nasal administration |
| 02/08/1989 | EP0302769A1 Lipid emulsion for parenteral or enteral nutrition |
| 02/08/1989 | EP0302754A2 Stable aqueous thrombin solution |
| 02/08/1989 | EP0302729A1 Stabilised anthracycline preparation |
| 02/08/1989 | EP0302473A2 Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
| 02/08/1989 | EP0302466A1 Cyclopeptides as absorption enhancers for administration on the mucous membranes |
| 02/08/1989 | EP0302175A2 Modified labeled nucleotides and polynucleotides and methods of preparing, utilizing and detecting same |
| 02/08/1989 | EP0302147A1 Topical tanning compositions |
| 02/08/1989 | EP0169111B1 Cytotoxic conjugates useful in therapy, and process for obtaining them |
| 02/07/1989 | US4803213 Jet-milled sugar organic acid; stable to pressure, humidity |
| 02/07/1989 | US4803196 B-lactam antibiotic, base carbon dioxide mixture |
| 02/07/1989 | US4803081 New pharmaceutical preparations with extended release |
| 02/07/1989 | US4803077 Crystallizing beta-maltose hydrate, for foods, cosmetics, emul sifiers |
| 02/07/1989 | US4803067 Compositions for cosmetics and dermatology comprising perfluoropolyethers |
| 02/07/1989 | US4803047 Method for neutralizing offensive chemicals |
| 02/07/1989 | US4802924 Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products |
| 02/07/1989 | CA1249825A1 Micronized 2-(4-chlorophenyl)-s-triazolo¬5,1- a| isoquinoline and its formulation for veterinary use |
| 02/07/1989 | CA1249782A1 Stabilized enzyme conjugate composition |
| 02/07/1989 | CA1249774A1 Cosmetic formulation |
| 02/02/1989 | DE3724691A1 Pharmazeutisches mittel zur lokalen therapie der psoriasis Pharmaceutical medium for local therapy of psoriasis |
| 02/01/1989 | EP0301970A1 Method for dissolving arginineamides and pharmaceutical compositions containing them |
| 02/01/1989 | EP0301969A1 Microparticles comprising a biodegradable polymer controlling the release of an antimalarial drug, pharmaceutical compositions containing them and process for their preparation |
| 02/01/1989 | EP0301856A2 Delivery system |
| 02/01/1989 | EP0301781A2 Cosmetic composition |
| 02/01/1989 | EP0301759A2 Bone cement for controlled release of substances |
| 02/01/1989 | EP0301424A2 Sustained-release percutaneous preparations |
| 02/01/1989 | EP0301423A1 Pharmaceutical compositions containing trapidil, and process for their preparation |
| 02/01/1989 | EP0301122A1 Use of soybean kunitz type trypsin and derivatives in the preparation of medicaments and agent comprising the same |
| 01/31/1989 | US4801688 Alkaloid derivatives, anticancer agents |
| 01/31/1989 | US4801587 Vasodilators |
| 01/31/1989 | US4801586 N-heterocycles |
| 01/31/1989 | US4801575 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 01/31/1989 | US4801461 Pseudoephedrine dosage form |
| 01/31/1989 | US4801460 Preparation of solid pharmaceutical forms |
| 01/31/1989 | US4801444 Medicinal preparation for individual prevention of venereal diseases and treatment of urogenital trichomoniasis |
| 01/31/1989 | CA1249519A1 Compressible starches as binders for tablets or capsules |
| 01/26/1989 | WO1989000692A1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
| 01/26/1989 | WO1989000583A1 Improved immunotoxin therapies utilizing purified ricin a-chain species |
| 01/26/1989 | WO1989000581A1 Lectines fixing beta-d-galactoside |
| 01/26/1989 | WO1989000563A1 High potency sweetening agents |
| 01/26/1989 | WO1989000557A1 Aminopolycarboxylic acids and derivatives thereof |
| 01/26/1989 | WO1989000419A1 Encapsulation by entrapment within starch matrix |
| 01/25/1989 | EP0300888A1 Ophthalmic composition containing rhamsan gum |
| 01/25/1989 | EP0300749A2 Injectable formulation containing 3-benzoyloxy-1,3,5(10)-estratriene-17-[4-[p-(bis(2-chloroethyl)amino)phenyl]-butanoyloxy]acetate |
| 01/25/1989 | EP0300526A2 Antiviral pharmaceutical compositions containing cyclodextrins |
| 01/25/1989 | EP0300282A1 Pharmaceutical and cosmetic compositions containing complexes of flavanolignans with phospholipids |
| 01/25/1989 | EP0300107A1 Ester, thioester and amide derivatives of oxolinic acid, process for their synthesis and their therapeutical use |
| 01/25/1989 | EP0300036A1 Vasopressin-based pharmaceutical compositions |
| 01/25/1989 | EP0150350B1 Cross-linked polymers, process for their manufacture and use thereof |
| 01/25/1989 | CN1030588A Functionalized polyamine chelants and rhodium complexes thereof and process for their preparation |
| 01/24/1989 | US4800087 Microencapsulation |
| 01/24/1989 | CA1249223A1 Solid drug formulations and stable suspensions |
| 01/24/1989 | CA1249222A1 Antibody compositions of therapeutic agents having an extended serum half-life |
| 01/24/1989 | CA1249198A1 Aqueous emulsions using cationic silanes |
| 01/19/1989 | DE3822557A1 Somatostatins |
| 01/18/1989 | EP0299846A1 Magnetizable microspheres based on polysiloxane, their preparation and their use |
| 01/18/1989 | EP0299795A2 Aminopolycarboxylic acids and derivatives thereof |
| 01/18/1989 | EP0299758A2 Compositions for enhancing the cutaneous penetration of pharmacologically active agents |
| 01/18/1989 | EP0299533A2 High potency sweetening agents |
| 01/18/1989 | EP0299528A1 Doxorubicin hydrochloride nonaqueous solution |
| 01/18/1989 | EP0299527A1 Doxorubicin hydrochloride aqueous solutions |
| 01/18/1989 | EP0299467A1 Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction |
| 01/18/1989 | EP0299211A1 DHP-coated tablet |
| 01/18/1989 | EP0299057A1 Potentiation of cytotoxic conjugates |
| 01/18/1989 | EP0299007A1 Preparation of 1-amino-1-deoxyoligosaccharides and derivatives thereof |
| 01/17/1989 | US4798846 Pharmaceutical compositions |
| 01/17/1989 | US4798725 Sustained release capsule |
| 01/17/1989 | US4798724 Solid, stable dosage forms with an elastic film coating |
| 01/17/1989 | US4798682 Oil-in-water emulsions with increased viscosity under shear stress |
| 01/17/1989 | CA1248876A1 Ibuprofen-containing soft gelatin capsules and process for preparing same |
| 01/17/1989 | CA1248874A1 Process for the preparation of antitumoral glycoproteins modified on their carbohydrate units |
| 01/12/1989 | WO1989000168A1 Novel interleukin-2 receptor and applications thereof |
| 01/12/1989 | WO1989000077A1 Lecithin gel |
| 01/12/1989 | WO1989000049A1 Method and therapeutic compositions for the prevention of fibrin deposition or adhesions |
| 01/11/1989 | EP0298740A1 Pediatric ibuprofen compositions |
| 01/11/1989 | EP0298654A2 Use of antibody/antigen interactions to protect or modulate biological activity |
| 01/11/1989 | EP0298192A1 Stable, injectable solutions of vincristine salts |
| 01/11/1989 | EP0202257B1 Composition for ophthalmological use |
| 01/10/1989 | US4797421 Oxidation resistance for vegetable oils, fats or cosmetics |
| 01/10/1989 | US4797405 Stabilized pergolide compositions |
| 01/10/1989 | US4797402 Corticosteroids, peppermint, urea |
| 01/10/1989 | US4797390 Inositol triphosphate pharmaceutical compositions |
| 01/10/1989 | US4797388 Pharmaceutical compositions with galactitol as carrier |
| 01/10/1989 | US4797286 Orally administerable sustained release pharmaceutical formulations |
| 01/10/1989 | US4797282 Drug depot containing cytostatics |
| 01/10/1989 | CA1248524A1 Complexes of prostaglandins |
| 01/10/1989 | CA1248523A1 OCCLUSION COMPOUND OF 2-NITROXYMETHYL-6- CHLOROPYRIDINE WITH .beta.-CYCLODEXTRIN AND PROCESS FOR PREPARATION THEREOF |
| 01/10/1989 | CA1248453A1 Pharmaceutical compositions containing anthracycline glycosides |
| 01/05/1989 | DE3721163A1 Traegermaterial fuer augenarzneimittel Traegermaterial for eye drug |
| 01/04/1989 | EP0297860A1 Method and therapeutic compositions for the prevention of fibrin deposition or adhesions |
| 01/04/1989 | EP0297535A2 Drug delivery devices |
| 01/04/1989 | EP0297294A1 Process for preparing a solution with a high specific volume activity of a protein with a tissue plasminogen activator activity (t-PA), solution containing the protein with t-PA activity and use of the solution in human and veterinary medicine |